5 reports of this reaction
2.0% of all GUAIFENESIN AND DEXTROMETHORPHAN HBR reports
#8 most reported adverse reaction
COUGH is the #8 most commonly reported adverse reaction for GUAIFENESIN AND DEXTROMETHORPHAN HBR, manufactured by CVS Pharmacy. There are 5 FDA adverse event reports linking GUAIFENESIN AND DEXTROMETHORPHAN HBR to COUGH. This represents approximately 2.0% of all 244 adverse event reports for this drug.
Patients taking GUAIFENESIN AND DEXTROMETHORPHAN HBR who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
COUGH is a less commonly reported adverse event for GUAIFENESIN AND DEXTROMETHORPHAN HBR, but still significant enough to appear in the safety profile.
In addition to cough, the following adverse reactions have been reported for GUAIFENESIN AND DEXTROMETHORPHAN HBR:
The following drugs have also been linked to cough in FDA adverse event reports:
COUGH has been reported as an adverse event in 5 FDA reports for GUAIFENESIN AND DEXTROMETHORPHAN HBR. This does not prove causation, but indicates an association observed in post-market surveillance data.
COUGH accounts for approximately 2.0% of all adverse event reports for GUAIFENESIN AND DEXTROMETHORPHAN HBR, making it a notable side effect.
If you experience cough while taking GUAIFENESIN AND DEXTROMETHORPHAN HBR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.